Emile Voest

Director/Board Member presso SANOFI

64 anni

Health Technology

Consumer Services

Health Services

Profilo

Emile Voest is the founder of the Hartwig Medical Foundation, founded in 2015, where he holds the title of Non-Executive Director.
He was also the founder of the Hubrecht Organoid Technology Foundation, founded in 2013, where he held the title of Medical Director from 2013 to 2016.
Additionally, Dr. Voest is the founder of the Center For Personalized Cancer Therapy, founded in 2010, where he currently serves as Director.
Dr. Voest's current job(s) include being an Independent Director at Sanofi since 2022 and a Professor at the University of Utrecht since 1999.
Dr. Voest's former job(s) include being the Director of the European Society for Medical Oncology from 2015 to 2020 and the Executive Medical Director of Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh from 2014 to 2020.
Dr. Voest obtained a doctorate degree from the University of Utrecht.

Posizioni attive di Emile Voest

Società	Posizione	Inizio
SANOFI	Director/Board Member	03/05/2022
Hartwig Medical Foundation	Founder	01/01/2015
Center For Personalized Cancer Therapy	Founder	01/01/2010
University of Utrecht	Corporate Officer/Principal	01/01/1999

Tutte le posizioni attive di Emile Voest

Precedenti posizioni note di Emile Voest

Società	Posizione	Fine
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh Investment Trusts/Mutual FundsMiscellaneous Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek is a scientific research institute and a specialist clinic. The firm’s areas of research are including fundamental, clinical and translational cancer research. The company was founded in 1916 and is headquartered in Amsterdam, Netherlands.	Chief Tech/Sci/R&D Officer	01/01/2020
European Society for Medical Oncology European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40.	Director/Board Member	01/01/2020
Hubrecht Organoid Technology Foundation	Founder	01/01/2016

Vedi nel dettaglio l'esperienza di Emile Voest

Formazione di Emile Voest

University of Utrecht

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Emile Voest

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
SANOFI	Health Technology

Aziende private	5
European Society for Medical Oncology European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40.	Health Services
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh Investment Trusts/Mutual FundsMiscellaneous Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek is a scientific research institute and a specialist clinic. The firm’s areas of research are including fundamental, clinical and translational cancer research. The company was founded in 1916 and is headquartered in Amsterdam, Netherlands.	Miscellaneous
Hubrecht Organoid Technology Foundation
Hartwig Medical Foundation
Center For Personalized Cancer Therapy

Vedi le connessioni aziendali